Pierre-Antoine Faye

9PUBLICATIONS
14CO-AUTHORS
Neurology and neuromuscular diseasesRegenerative medicine (incl. stem cells)Medical molecular engineering of nucleic acids and proteinsMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 13, 2025
From in vivo models to in vitro bioengineered neuromuscular junctions for the study of Charcot-Marie-Tooth disease.

Camille Scherrer, Camille Loret, Nicolas Védrenne

|Jul 27, 2024
CRISPR Base Editing to Create Potential Charcot-Marie-Tooth Disease Models with High Editing Efficiency: Human Induced Pluripotent Stem Cell Harboring SH3TC2 Variants.

Camille Loret, Amandine Pauset, Pierre-Antoine Faye

|Mar 28, 2024
Readthrough Activators and Nonsense-Mediated mRNA Decay Inhibitor Molecules: Real Potential in Many Genetic Diseases Harboring Premature Termination Codons.

Nesrine Benslimane, Camille Loret, Pauline Chazelas

|Jul 29, 2023
Amlexanox: Readthrough Induction and Nonsense-Mediated mRNA Decay Inhibition in a Charcot-Marie-Tooth Model of hiPSCs-Derived Neuronal Cells Harboring a Nonsense Mutation in GDAP1 Gene.

Nesrine Benslimane, Federica Miressi, Camille Loret

|Aug 27, 2021
GDAP1 Involvement in Mitochondrial Function and Oxidative Stress, Investigated in a Charcot-Marie-Tooth Model of hiPSCs-Derived Motor Neurons.

Federica Miressi, Nesrine Benslimane, Frédéric Favreau

|Dec 18, 2020
One Multilocus Genomic Variation Is Responsible for a Severe Charcot-Marie-Tooth Axonal Form.

Federica Miressi, Corinne Magdelaine, Pascal Cintas

Pageof 2

Frequent Collaborators

6 joint publications

Franck Sturtz

6 joint publications

Frédéric Favreau

5 joint publications

Anne-Sophie Lia

4 joint publications

Camille Loret